JP2020512375A5 - - Google Patents

Download PDF

Info

Publication number
JP2020512375A5
JP2020512375A5 JP2019553504A JP2019553504A JP2020512375A5 JP 2020512375 A5 JP2020512375 A5 JP 2020512375A5 JP 2019553504 A JP2019553504 A JP 2019553504A JP 2019553504 A JP2019553504 A JP 2019553504A JP 2020512375 A5 JP2020512375 A5 JP 2020512375A5
Authority
JP
Japan
Prior art keywords
seq
peptide
cancer
epitope
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019553504A
Other languages
English (en)
Japanese (ja)
Other versions
JP7346302B2 (ja
JP2020512375A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/024831 external-priority patent/WO2018183488A1/en
Publication of JP2020512375A publication Critical patent/JP2020512375A/ja
Publication of JP2020512375A5 publication Critical patent/JP2020512375A5/ja
Application granted granted Critical
Publication of JP7346302B2 publication Critical patent/JP7346302B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019553504A 2017-03-28 2018-03-28 ヒトpd-1ペプチドワクチン及びその使用法 Active JP7346302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762477895P 2017-03-28 2017-03-28
US62/477,895 2017-03-28
PCT/US2018/024831 WO2018183488A1 (en) 2017-03-28 2018-03-28 Human pd1 peptide vaccines and uses thereof

Publications (3)

Publication Number Publication Date
JP2020512375A JP2020512375A (ja) 2020-04-23
JP2020512375A5 true JP2020512375A5 (cg-RX-API-DMAC7.html) 2021-05-06
JP7346302B2 JP7346302B2 (ja) 2023-09-19

Family

ID=63678120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019553504A Active JP7346302B2 (ja) 2017-03-28 2018-03-28 ヒトpd-1ペプチドワクチン及びその使用法

Country Status (11)

Country Link
US (1) US11684660B2 (cg-RX-API-DMAC7.html)
EP (1) EP3600398B1 (cg-RX-API-DMAC7.html)
JP (1) JP7346302B2 (cg-RX-API-DMAC7.html)
KR (1) KR102653567B1 (cg-RX-API-DMAC7.html)
CN (2) CN110636855B (cg-RX-API-DMAC7.html)
AU (2) AU2018243920B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019020386A2 (cg-RX-API-DMAC7.html)
CA (1) CA3058393A1 (cg-RX-API-DMAC7.html)
ES (1) ES2963635T3 (cg-RX-API-DMAC7.html)
RU (1) RU2019131252A (cg-RX-API-DMAC7.html)
WO (1) WO2018183488A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021512966A (ja) * 2018-02-07 2021-05-20 イミュジーン、リミテッドImugene Limited ワクチン組成物およびその使用
WO2020071869A1 (ko) * 2018-10-05 2020-04-09 알엔에이진 주식회사 표적 세포 특이적으로 결합하여 다중 면역기능이 강화된 키메라항원 및 이의용도
BR112022005044A2 (pt) 2019-09-17 2022-07-05 Ohio State Innovation Foundation Peptídeo quimérico, peptídeo sintético, composição farmacêutica, anticorpo, método de tratamento
WO2023205796A2 (en) * 2022-04-21 2023-10-26 Ohio State Innovation Foundation Human ctla-4 peptide vaccines and uses thereof
WO2024211745A1 (en) * 2023-04-05 2024-10-10 Ohio State Innovation Foundation Human pd1, pd-l1, and ctla-4 combination peptide vaccines and uses thereof
CN119019569B (zh) * 2024-08-19 2025-10-24 中国人民解放军陆军军医大学 一种可定向增强胸腺新生t细胞杀伤乳腺癌的多肽及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1601438A (cg-RX-API-DMAC7.html) 1968-10-17 1970-08-24
US4342566A (en) 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US5652138A (en) 1992-09-30 1997-07-29 The Scripps Research Institute Human neutralizing monoclonal antibodies to human immunodeficiency virus
CA2163032C (en) 1993-06-03 2001-02-06 John Landon Antibody fragments in therapy
CN1215404A (zh) * 1996-04-03 1999-04-28 佩普里瑟奇公司 非树状骨架肽载体
FR2765243B1 (fr) 1997-06-30 1999-07-30 Usinor Acier inoxydable austenoferritique a tres bas nickel et presentant un fort allongement en traction
CA2534060C (en) * 2003-07-30 2012-06-12 Vaccine Research Institute Of San Diego Hepatitis virus core proteins as vaccine platforms and methods of use thereof
GB0400440D0 (en) * 2004-01-09 2004-02-11 Isis Innovation Receptor modulators
EP3530736A3 (en) 2005-05-09 2019-11-06 ONO Pharmaceutical Co., Ltd. Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
EP1912680B1 (en) 2005-06-15 2014-11-26 The Ohio State University Research Foundation Her-2 peptides
NZ582823A (en) * 2007-07-27 2012-04-27 Immatics Biotechnologies Gmbh Composition of tumour-associated peptides and related anti-cancer vaccine
WO2010011315A2 (en) * 2008-07-25 2010-01-28 Viral Genetics, Inc. Proteins for use in diagnosing and treating infection and disease
US20100234283A1 (en) * 2009-02-04 2010-09-16 The Ohio State University Research Foundation Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
US8907053B2 (en) * 2010-06-25 2014-12-09 Aurigene Discovery Technologies Limited Immunosuppression modulating compounds
RU2623161C2 (ru) * 2011-04-15 2017-06-22 Компуджен Лтд. Полипептиды и полинуклеотиды и их применение для лечения иммунологических нарушений и рака
EP2744830A4 (en) * 2012-06-21 2015-06-17 Compugen Ltd LSR ANTIBODIES AND USES THEREOF FOR THE TREATMENT OF CANCER
CA2884704C (en) * 2012-09-07 2023-04-04 Randolph J. Noelle Vista modulators for diagnosis and treatment of cancer
WO2014161509A1 (en) * 2013-04-05 2014-10-09 The University Of Hong Kong Novel pd1 isoforms, and uses thereof for potentiating immune responses
DK2992020T3 (da) * 2013-05-03 2020-02-10 Ohio State Innovation Foundation Cs1-specifik kimær antigenreceptor-manipulerede immuneffektorceller
TWI676636B (zh) * 2013-07-12 2019-11-11 Vlp醫療股份有限公司 包含pd-1抗原或pd-1配體抗原的類病毒粒子
TWI720946B (zh) 2014-08-08 2021-03-11 美商Vlp醫療股份有限公司 包含改質套膜蛋白質e3之類病毒粒子
EP3177640B1 (en) * 2014-08-08 2020-05-06 The Board of Trustees of the Leland Stanford Junior University High affinity pd-1 agents and methods of use
CA2971734C (en) * 2014-12-22 2025-11-18 Pd-1 Acquisition Group, Llc Anti-pd-1 antibodies

Similar Documents

Publication Publication Date Title
RU2019131252A (ru) Пептидные вакцины на основе pd1 человека и их применение
ES2966473T3 (es) Derivados de camptotecina
CN110267686B (zh) 吡咯并苯并二氮杂䓬-抗体缀合物
JP2022090057A (ja) 抗cdh6抗体及び抗cdh6抗体-薬物コンジュゲート
JP2023011799A (ja) 抗体-薬物コンジュゲート
JP2025114615A (ja) 治療薬としての細胞毒素のペプチドコンジュゲート
JP2023502503A (ja) DuoCARによりがんを処置するための組成物および方法
JP2023510905A5 (cg-RX-API-DMAC7.html)
JP2020505955A5 (cg-RX-API-DMAC7.html)
JP2023505708A5 (cg-RX-API-DMAC7.html)
JP2016518382A (ja) Axl抗体薬物複合体および癌の治療のためのその使用
JP2016503295A5 (cg-RX-API-DMAC7.html)
TW202146057A (zh) 半胱胺酸工程改造抗體之結合物
RU2009149462A (ru) АНТИТЕЛА ПРОТИВ NRR Notch1 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
TW202108181A (zh) 抗trop2抗體及其生產方法、及抗trop2抗體-藥物結合物
CN108601952B (zh) 雷公藤内酯的葡萄糖缀合物、类似物及其用途
JP2010531140A5 (cg-RX-API-DMAC7.html)
HRP20180262T1 (hr) Monoklonska anti-gt468 protutijela za liječenje karcinoma
CN117462695A (zh) 吡咯并苯并二氮杂䓬-抗体缀合物
JP2023519261A5 (cg-RX-API-DMAC7.html)
JP2019530707A (ja) イソキノリジノベンゾジアゼピン(iqb)−1(クロロメチル)−2,3−ジヒドロ−1h−ベンゾ[e]インドール(cbi)二量体
TW202535885A (zh) 配體-藥物偶聯物、偶聯連接子及其用途
JP2022548364A5 (cg-RX-API-DMAC7.html)
JP2020535811A5 (cg-RX-API-DMAC7.html)
JP2022518150A5 (cg-RX-API-DMAC7.html)